Avoiding Diabetes After Pregnancy Trial in Moms (ADAPT-M)
Avoiding Diabetes After Pregancy Trial in Moms (ADAPT-M): Pilot, Feasibility and Effectiveness Phases
Sponsor: Canadian Institutes of Health Research (CIHR)
A NA clinical study on Diabetes, this trial is completed. The trial is conducted by Canadian Institutes of Health Research (CIHR) and has accumulated 10 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
May 2021 — Apr 2023 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Recruiting NA
-
Oct 2018 — Jun 2020 [monthly]
Recruiting NA
-
Jun 2018 — Oct 2018 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- Diabetes Canada
- J.P. Bickell Foundation
- Michael Garron Hospital
- Mount Sinai Hospital, Canada
- Scarborough Rouge Hospital
- Sunnybrook Health Sciences Centre
- The Lawson Foundation
- Unity Health Toronto
- Women's College Hospital
For direct contact, visit the study record on ClinicalTrials.gov .